In vitro antibacterial activity of rifaximin against Campylobacter pylori (Campylobacter pyloridis). 1989

F Mignini, and E Falcioni, and M Prenna, and F Santacroce, and S Ripa
Department of Cellular Biology, Chair of Microbiology, Faculty of Pharmacy, University of Camerino, Italy.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002169 Campylobacter Infections Infections with bacteria of the genus CAMPYLOBACTER. Campylobacter Infection,Campylobacteriosis,Infections, Campylobacter,Campylobacterioses,Infection, Campylobacter
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078262 Rifaximin A synthetic rifamycin derivative and anti-bacterial agent that is used for the treatment of GASTROENTERITIS caused by ESCHERICHIA COLI INFECTIONS. It may also be used in the treatment of HEPATIC ENCEPHALOPATHY. 4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin,L 105,L-105,Redactiv,Xifaxan,L105
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012294 Rifamycins A group of ANTI-BACTERIAL AGENTS characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known ANTI-BACTERIAL AGENTS. They have been isolated from fermentation broths of Streptomyces mediterranei. Rifamycin,Rifomycin,Rifomycins
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae

Related Publications

F Mignini, and E Falcioni, and M Prenna, and F Santacroce, and S Ripa
February 1994, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
F Mignini, and E Falcioni, and M Prenna, and F Santacroce, and S Ripa
September 1987, Antimicrobial agents and chemotherapy,
F Mignini, and E Falcioni, and M Prenna, and F Santacroce, and S Ripa
December 1989, The Journal of antimicrobial chemotherapy,
F Mignini, and E Falcioni, and M Prenna, and F Santacroce, and S Ripa
August 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
F Mignini, and E Falcioni, and M Prenna, and F Santacroce, and S Ripa
February 1990, Journal of clinical pathology,
F Mignini, and E Falcioni, and M Prenna, and F Santacroce, and S Ripa
March 2022, Journal of ethnopharmacology,
F Mignini, and E Falcioni, and M Prenna, and F Santacroce, and S Ripa
May 1990, Journal of clinical pathology,
F Mignini, and E Falcioni, and M Prenna, and F Santacroce, and S Ripa
December 1989, Enfermedades infecciosas y microbiologia clinica,
F Mignini, and E Falcioni, and M Prenna, and F Santacroce, and S Ripa
October 2015, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,
F Mignini, and E Falcioni, and M Prenna, and F Santacroce, and S Ripa
January 2010, Biological & pharmaceutical bulletin,
Copied contents to your clipboard!